Spyre Therapeutics, Inc. - SYRE

Include option trades

Include indirect trades

EDGAR CIK

1 Month 3 Month 6 Month 1 Year 2 Years

Buy Breakdown

No buy transactions for this time period.

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
09/03/2024	09/05/2024	Burrows Scott L Chief Financial Officer CFO	Sell	-18,531 @ $28.17	($522,073.86)	116,422	(-13.73%)	Direct